|
Sanofi's dengue vaccine
approved in 11 countries
Send a link to a friend
[October 04, 2016]
PARIS (Reuters) - Sanofi Pasteur,
Sanofi's vaccines unit, said on Tuesday that its dengue vaccine,
Dengvaxia, had received market approval in eleven countries.
|
|
 To date the vaccine has been approved in Mexico, the Philippines,
Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru,
Indonesia, Thailand and Singapore, the statement said.
Dengue fever is a mosquito-borne disease caused by four virus
serotypes (1 to 4) as categorized by the World Health Organisation.
Overall, the disease is seen as a threat to about half of the
world's population. Some 400 million people are believed to be
infected annually.
(Reporting by Dominique Vidalon; Editing by Sunil Nair)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
|
